Clorox Co (CLX) Stake Lessened by Exxonmobil Investment Management Inc. TX
Exxonmobil Investment Management Inc. TX decreased its holdings in Clorox Co (NYSE:CLX) by 13.0% during the 4th quarter, Holdings Channel reports. The firm owned 20,502 shares of the company’s stock after selling 3,068 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in Clorox were worth $3,049,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of CLX. Janus Henderson Group PLC increased its stake in shares of Clorox by 8,008.5% in the 2nd quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after purchasing an additional 1,307,153 shares during the last quarter. Vanguard Group Inc. grew its position in Clorox by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after acquiring an additional 369,918 shares during the last quarter. APG Asset Management N.V. grew its position in Clorox by 30.9% during the 3rd quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock worth $171,736,000 after acquiring an additional 307,700 shares during the last quarter. Renaissance Technologies LLC grew its position in Clorox by 24.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after acquiring an additional 263,700 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in Clorox by 63.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock worth $54,269,000 after acquiring an additional 161,555 shares during the last quarter. Institutional investors own 73.14% of the company’s stock.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the sale, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.
CLX has been the topic of a number of research reports. BMO Capital Markets restated a “buy” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, October 5th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $163.00 price objective on the stock in a research report on Monday, January 8th. Morgan Stanley reduced their price objective on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Jefferies Group restated a “hold” rating and set a $132.00 price objective on shares of Clorox in a research report on Wednesday, November 1st. Finally, Royal Bank of Canada restated a “hold” rating and set a $115.00 price objective on shares of Clorox in a research report on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $134.33.
Shares of Clorox Co (NYSE CLX) opened at $140.96 on Friday. Clorox Co has a 52-week low of $118.41 and a 52-week high of $150.40. The company has a market capitalization of $18,180.00, a PE ratio of 25.86, a price-to-earnings-growth ratio of 3.71 and a beta of 0.42. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the previous year, the company posted $1.36 EPS. The business’s revenue was up 4.0% on a year-over-year basis. equities research analysts expect that Clorox Co will post 5.7 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.38%. Clorox’s dividend payout ratio (DPR) is presently 61.65%.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.